Search results
Improve the outcome of high mortality cancers
- Cancer is one of the world’s greatest health challenges. There is much to do to advance the prevention, treatment and cure of this disease. UNSW Medicine & Health’s cancer research aims to improve the outcome of high mortality cancers – where the responses to current medicine and procedures are yet to change.
www.unsw.edu.au › medicine-health › research-impact
6 days ago · UNSW Medicine & Health’s cancer research aims to improve the outcome of high mortality cancers – where the responses to current medicine and procedures are yet to change. We help turn scientific discoveries into cures.
People also ask
What is UNSW Medicine & Health doing about cancer?
What is UNSW Medicine & Health?
How does UNSW Medicine & Health contribute to paediatric cancer research?
Our research continues to advance medicine and transform the outlook for cancer patients. This includes better treatment options and survival rates, which has so far helped hundreds of thousands of people in Australia to either outlast cancer or survive with it.
Cancer is the most pressing health challenge of our time. By the age of 85, cancer will affect 1 in 2 Australians. While health and medical research has improved the outlook for cancer patients in recent decades, cancer is still a leading cause of death worldwide.
May 13, 2024 · A new research centre focused on improving the care and wellbeing of cancer survivors will be established as part of a new 10-year partnership between UNSW Sydney and Cancer Council NSW (CCNSW).
Feb 4, 2019 · Professor Michael Barton OAM leads UNSW Medicine’s cancer research theme. As a health service researcher in cancer, his research focuses on assessing the demand for cancer services and therapies on a global scale.
Feb 6, 2019 · Their expertise spans the basic sciences, clinical trials, implementation research, public health and health services research – and it aims to benefit people at all stages of their encounter with cancer, from prevention to treatment, palliation and survivorship support.
Jan 12, 2022 · UNSW Medicine & Health Associate Professor David Ziegler and senior staff specialist at the Kids Cancer Centre at Sydney Children’s Hospital will lead a platform trial of combination precision-guided therapies for high-risk childhood cancer.
